These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 29048612)
1. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma. Liao B; Zhou H; Liang H; Li C Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma. Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164 [TBL] [Abstract][Full Text] [Related]
3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177 [TBL] [Abstract][Full Text] [Related]
5. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972 [TBL] [Abstract][Full Text] [Related]
6. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma. Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma. Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040 [TBL] [Abstract][Full Text] [Related]
8. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1. Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway. Hou Z; Quan J Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein. Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960 [TBL] [Abstract][Full Text] [Related]
12. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling. He B; Peng F; Li W; Jiang Y J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989 [TBL] [Abstract][Full Text] [Related]
13. HBx-induced miR-21 suppresses cell apoptosis in hepatocellular carcinoma by targeting interleukin-12. Yin D; Wang Y; Sai W; Zhang L; Miao Y; Cao L; Zhai X; Feng X; Yang L Oncol Rep; 2016 Oct; 36(4):2305-12. PubMed ID: 27571873 [TBL] [Abstract][Full Text] [Related]
14. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415 [TBL] [Abstract][Full Text] [Related]
15. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma. Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein and hypoxia‑inducible factor-1α stimulate Notch gene expression in liver cancer cells. Yang SL; Ren QG; Zhang T; Pan X; Wen L; Hu JL; Yu C; He QJ Oncol Rep; 2017 Jan; 37(1):348-356. PubMed ID: 27840976 [TBL] [Abstract][Full Text] [Related]
17. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells. Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140 [TBL] [Abstract][Full Text] [Related]
20. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation. Niu LJ; Huang T; Wang L; Sun XF; Zhang YM Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]